POZEN, Inc. (NASDAQ:POZN)

CAPS Rating: 3 out of 5

A pharmaceutical company focused on developing products which can provide improved efficacy, safety or patient convenience in the treatment of acute and chronic pain and pain related conditions.

Recs

1
Player Avatar NuclearSteve (< 20) Submitted: 12/29/2011 12:49:57 PM : Outperform Start Price: $3.91 POZN Score: +72.49

Article from Zacks Biotech Guy - Jason Napodano - trying a strategy where I set 10% stops on all these and let the winners run.

Featured Broker Partners


Advertisement